Pathologic stage I non–small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: Clinicopathologic characteristics and prognosis

Revisions in the International System for Staging Lung Cancer

Clifton F. Mountain · CHEST Journal · 1997 · 4.6K citations

Medicine, Oncology, Surgery +13

Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

New England Journal of Medicine · 2004 · 2.4K citations

Medicine, Oncology, Chemotherapy +14

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

Timothy Winton, Robert B. Livingston, David C. Johnson et al. · New England Journal of Medicine · 2005 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

Jean‐Yves Douillard, Rafael Rosell, Mario De Lena et al. · The Lancet Oncology · 2006 · 1.6K citations

Medicine, Oncology, Pharmacology +12

RETRACTED: A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung Cancer

Anil Potti, Sayan Mukherjee, Rebecca P. Petersen et al. · New England Journal of Medicine · 2006 · 577 citations · Full text

Medicine, Bioinformatics, Oncology +16